At the news
? BEARISHIMPACT 6/10 8-K filed Jul 31, 2026 at 07:23 ET
Inovio Pharmaceuticals priced a $20M public offering of 21M shares and warrants for 42M shares (or pre-funded warrants) at $0.95/unit, with net proceeds of ~$18.3M. The underwriter exercised an option for additional warrants covering 6.3M shares. This dilutive capital raise follows a prior going-concern disclosure and adds ~30% immediate dilution plus significant warrant overhang, reinforcing the bearish outlook.
- Offering of 21,052,632 shares and warrants to purchase up to 42,105,264 shares at $0.95/unit
- Underwriter exercised option for warrants to purchase an additional 6,315,788 shares
- Net proceeds expected to be approximately $18.3 million
- Warrants have a $1.10 exercise price, 5-year term, with beneficial ownership limitations
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access